Antimetastatic properties and DNA interactions of the novel class of dimeric Ru(III) compounds Na2[{trans-RuCl4(Me2SO)}2(μ-L)] (L = ditopic, non-chelating aromatic N-ligand). A preliminary investigation

Journal of Inorganic Biochemistry

Volumn 79, Issue 1-4, 2000, Pages 173-177

  Alessio, Enzo ^a   Iengo, Elisabetta ^a   Zorzet, Sonia ^a   Bergamo, Alberta ^b   Coluccia, Mauro ^c   Boccarelli, Angela ^c   Sava, Gianni ^a,b  

^a UNIVERSITY OF TRIESTE   (Italy)

^b Callerio Foundation   (Italy)

^c UNIVERSITY OF BARI   (Italy)

Author keywords

Antimetastatic activity; Dinuclear ruthenium(III) complexes; DNA binding; Interstrand cross links

Indexed keywords

ANTIMETASTATIC AGENT; RUTHENIUM DERIVATIVE; SODIUM DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CONTROLLED STUDY; DNA CROSS LINKING; DOSE TIME EFFECT RELATION; DRUG DNA INTERACTION; METASTASIS INHIBITION; MOUSE; NONHUMAN; TUMOR GROWTH;

ANIMALS; ANTINEOPLASTIC AGENTS; DIMERIZATION; DNA; FEMALE; LIGANDS; LUNG NEOPLASMS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED CBA; ORGANOMETALLIC COMPOUNDS; RUTHENIUM;

ANIMALIA; MURINAE;

EID: 0034732651     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-0134(99)00231-7     Document Type: Article

References (17)

1. E. Alessio, E. Iengo, G. Mestroni, G. Sava, Ital. Patent Applic. MI99A000811 (1999).
2. E. Iengo, G. Mestroni, M. Calligaris, S. Geremia, E. Alessio, J. Chem. Soc., Dalton Trans. (1999) 3361.
3. G. Mestroni, E. Alessio, G. Sava, S. Pacor, M. Coluccia, in: B.K. Keppler (Ed.), Metal Complexes in Cancer Chemotherapy, VCH, Weinheim, 1993, pp 157-185.
4. Sava G., Pacor S., Alessio E., Mestroni G., Gagliardi R., Cocchietto M., Coluccia M. Drugs Future. 18:1993;894.
5. Mestroni G., Alessio E., Sava G., Pacor S., Coluccia M., Boccarelli A. Met.-Based Drugs. 1:1994;41.
6. G. Mestroni, E. Alessio, G. Sava, Int. Patent No. WO 98/00431 (8 Jan. 1998).
7. Sava G., Capozzi I., Clerici K., Gagliardi G., Alessio E., Mestroni G. Clin. Exp. Metastasis. 16:1998;371.
8. Sava G., Gagliardi R., Cocchietto M., Clerici K., Capozzi I., Marella M., Alessio E., Mestroni G., Milanino R. Pathol. Oncol. Res. 4:1998;30.
9. Sava G., Clerici K., Capozzi I., Cocchietto M., Gagliardi R., Alessio E., Mestroni G., Perbellini A. Anti-Cancer Drugs. 10:1999;129.
10. Bergamo A., Gagliardi R., Scarcia V., Furlani A., Alessio E., Mestroni G., Sava G. J. Pharmacol. Exp. Ther. 298:1999;559.
11. G. Sava, E. Alessio, A. Bergamo, G. Mestroni, in: M.J. Clarke, P.J. Sadler (Eds.), Topics in Biological Inorganic Chemistry, vol. 1, Springer, Berlin, 1999, pp 143-169.
12. Farrell N. Comments Inorg. Chem. 16:1995;373.
13. N. Farrell, Y. Qu, U. Bierbach, M. Valsecchi, E. Menta, in B. Lippert (Ed.), Cisplatin - Chemistry and Biochemistry of a Leading Anticancer Drug, VHCA, Zurich, and Wiley-VCH, Weinheim, 1999, pp. 479-496.
14. Sava G., Pacor S., Coluccia M., Mariggio M., Cocchietto M., Alessio E., Mestroni G. Drug Invest. 8:1994;150.
15. Messori L., Kratz F., Alessio E. Met.-Based Drugs. 3:1996;1.
16. L. Messori, P. Orioli, D. Vullo, E. Alessio, E. Iengo, Eur. J. Biochem., in press.
17. Barca A., Pani B., Tamaro M., Russo E. Mutat. Res. 423:1999;171.